Pretreatment with glucose increases entry of urocortin into mouse brain
- PMID: 11337097
- DOI: 10.1016/s0196-9781(01)00397-7
Pretreatment with glucose increases entry of urocortin into mouse brain
Abstract
Although urocortin is a potent inhibitor of food ingestion after peripheral administration, it was recently shown that under normal conditions this peptide crosses the blood-brain barrier (BBB) at a very slow rate. We examined whether hyperglycemia could stimulate the rate of entry (K(i)) of (125)I-urocortin into the mouse brain. In euglycemic mice, (125)I-urocortin injected iv entered the brain at a rate similar to that of the vascular marker (99m)Tc-albumin. However, injection of glucose (3 g/kg, ip) 0.5, 1, or 2 h before the (125)I-urocortin greatly increased the influx of urocortin. Without the glucose, the self-inhibition characteristic of a saturable transport system was not apparent. Self-inhibition could be demonstrated after the glucose injection, indicating activation of a transport system for urocortin that was saturable. Injection of insulin (10 U/kg, ip) 1 or 2 h before the (125)I-urocortin decreased the K(i). Thus, the entry of urocortin into brain can be activated by changes in the concentration of blood glucose, illustrating the responsiveness of the BBB to regulatory influences.
Similar articles
-
Activation of urocortin transport into brain by leptin.Peptides. 2000 Dec;21(12):1811-7. doi: 10.1016/s0196-9781(00)00349-1. Peptides. 2000. PMID: 11150641
-
Glucose and insulin increase the transport of leptin through the blood-brain barrier in normal mice but not in streptozotocin-diabetic mice.Neuroendocrinology. 2001 Apr;73(4):237-42. doi: 10.1159/000054640. Neuroendocrinology. 2001. PMID: 11340337
-
Modulation of feeding-related peptide/protein signals by the blood-brain barrier.J Neurochem. 2004 Jul;90(2):455-61. doi: 10.1111/j.1471-4159.2004.02502.x. J Neurochem. 2004. PMID: 15228601
-
[Urocortin: molecular biology and cardiovascular effects].G Ital Cardiol (Rome). 2007 Apr;8(4):236-45. G Ital Cardiol (Rome). 2007. PMID: 17506295 Review. Italian.
-
Involvement of the Blood-Brain Barrier in Metabolic Regulation.CNS Neurol Disord Drug Targets. 2016;15(9):1118-1128. doi: 10.2174/1871527315666160920124928. CNS Neurol Disord Drug Targets. 2016. PMID: 27658512 Review.
Cited by
-
Cytokine signaling modulates blood-brain barrier function.Curr Pharm Des. 2011 Nov;17(33):3729-40. doi: 10.2174/138161211798220918. Curr Pharm Des. 2011. PMID: 21834767 Free PMC article. Review.
-
Systemic administration of urocortin after intracerebral hemorrhage reduces neurological deficits and neuroinflammation in rats.J Neuroinflammation. 2012 Jan 19;9:13. doi: 10.1186/1742-2094-9-13. J Neuroinflammation. 2012. PMID: 22257737 Free PMC article.
-
Urocortin and the brain.Prog Neurobiol. 2008 Feb;84(2):148-56. doi: 10.1016/j.pneurobio.2007.10.008. Epub 2007 Nov 7. Prog Neurobiol. 2008. PMID: 18078706 Free PMC article. Review.
-
Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides.Curr Pharm Des. 2008;14(16):1615-9. doi: 10.2174/138161208784705423. Curr Pharm Des. 2008. PMID: 18673203 Free PMC article. Review.
-
Concepts for biologically active peptides.Curr Pharm Des. 2010 Oct;16(30):3390-400. doi: 10.2174/138161210793563491. Curr Pharm Des. 2010. PMID: 20726835 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical